Stifel Financial
FBRX icon

Stifel Financial’s Forte Biosciences FBRX Stock Holding History

Stifel Financial’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-98
Closed -$245K – 2884
2019
Q2 		$245K Buy
98
+25
+34% +$74.1K ﹤0.01% 2604
2019
Q1 		$297K Buy
73
+3
+4% +$11.6K ﹤0.01% 2369
2018
Q4 		$215K Buy
70
+17
+32% +$73.2K ﹤0.01% 2427
2018
Q3 		$307K Buy
+53
New +$202K ﹤0.01% 2346

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Stifel Financial's FBRX Position: Q3 2019 in Review

Stifel Financial sold out of Forte Biosciences (FBRX) in Q3 2019, closing a stake of 98 shares — an estimated $245K sold.

Stifel Financial first reported a position in FBRX in Q3 2018 and held it in 4 quarters. The position peaked at $307K in Q3 2018. 58 funds tracked by Wall St. Rank hold FBRX as of Q3 2019.

  • Stifel Financial reported no remaining Forte Biosciences position as of Q3 2019 after selling out during the quarter.
  • Stifel Financial sold 98 Forte Biosciences shares in Q3 2019, an estimated $245K.
  • Stifel Financial first reported a position in Forte Biosciences in Q3 2018 and held it in 4 quarters.
  • Stifel Financial's Forte Biosciences position peaked at $307K in Q3 2018.
  • 58 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2019.

Based on Stifel Financial's 13F filing for Q3 2019, filed 13 Nov 2019.